Form 8-K - Current report:
SEC Accession No. 0001437749-25-010087
Filing Date
2025-03-31
Accepted
2025-03-31 14:09:25
Documents
15
Period of Report
2025-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20250331_8k.htm   iXBRL 8-K 25781
2 EXHIBIT 99.1 ex_797052.htm EX-99.1 4597
  Complete submission text file 0001437749-25-010087.txt   171148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250331.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250331_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250331_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250331_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250331_8k_htm.xml XML 2842
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 25791565
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)